CordenPharma, a global CDMO in the manufacturing of drug substance (APIs) complex modalities (such as peptides, oligos and lipids) and injectable drug products, and GENEPEP, a French CRO specializing in the design, chemical synthesis, and optimization of peptides, have celebrated one year of their collaboration. 

   The partnership, signed in 2023, supports biotech companies with the development, discovery, and manufacturing of peptides for early clinical phase, leveraging CordenPharma’s cGMP...